Sutro Biopharma
STRO
STRO
115 hedge funds and large institutions have $248M invested in Sutro Biopharma in 2023 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 50 increasing their positions, 30 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
38% less capital invested
Capital invested by funds: $398M → $248M (-$151M)
60% less call options, than puts
Call options by funds: $2K | Put options by funds: $5K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
115
Holding in Top 10
–
Calls
$2K
Puts
$5K
Top Buyers
| 1 | +$5.31M | |
| 2 | +$4.95M | |
| 3 | +$4.56M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.34M |
| 5 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$2.3M |
Top Sellers
| 1 | -$6.39M | |
| 2 | -$2.5M | |
| 3 | -$2.28M | |
| 4 |
Millennium Management
New York
|
-$2.21M |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$2.12M |